1. Conference Day, 02. September 2025

8:30 - 9:10 Registration for the main conference with coffee

9:15 - 9:20 Opening of the first day of the conference by the Chair

Jessica Cordes - INTERIM HEAD OF CLINICAL OPERATIONS, Clinical Excellence GmbH
img

Jessica Cordes

INTERIM HEAD OF CLINICAL OPERATIONS
Clinical Excellence GmbH

9:20 - 9:50 Opening-Keynote: Digital twins: Enabling precision oncology 2.0

Rafik Fellague-Chebra - Executive Global Group medical Director, Solid tumors franchise, GI cancers, Novartis

-From precision oncology to precision oncology 2.0: How AI and multi-omics integration are redefining individualized care strategies.

-The role of digital twins: Using virtual patient models to simulate disease progression, treatment responses, and predict outcomes.

-Use case in clinical development: Accelerating trial design, patient recruitment, and adaptive protocol optimization through predictive analytics.

-Regulatory and ethical considerations: What needs to be addressed for digital twin models and AI to be clinically validated and adopted.

img

Rafik Fellague-Chebra

Executive Global Group medical Director, Solid tumors franchise, GI cancers
Novartis

-Opportunities and Challenges – How are digital technologies and AI changing the efficiency, quality, and ethics of clinical trials?

-Automation and Data Analytics – What role does AI play in patient recruitment, data analysis, and decision-making?

-Future Perspectives – How can regulatory frameworks and technological innovations further advance the development of clinical trials?

-Human vs. Machine – How does the human factor remain relevant and crucial in an increasingly AI-driven research environment?

img

Roberta Pandolfi

Analytics Innovation Strategist
Boehringer Ingelheim

img

Dr. Frank Richard

Vice President Medical, AI and Machine Learning, Oncology Drug Development
Heidelberg Pharma AG

img

Rafik Fellague-Chebra

Executive Global Group medical Director, Solid tumors franchise, GI cancers
Novartis

img

Jessica Cordes

INTERIM HEAD OF CLINICAL OPERATIONS
Clinical Excellence GmbH

10:20 - 10:50 Coffee break with networking opportunity

  • Application of AI-based airway segmentation and mucous plug detection in clinical trial settings 
  • Advantages and limitations of radiology-based outcomes in comparison to traditional functional measures 
img

Federico Mollica

Postdoctoral Researcher- Imaging Scientist
Charite Universittsmedizin Berlin

  • How Gen AI can help simplify medical jargon and improve patient understanding
  • Empowering healthcare teams to leverage AI tools for creating patient education materials that use confirmed patient-friendly language
  • Measuring the impact of AI-augmented patient education Dimitri Metzger Technology Lead in Healthcare R&D, Merck Group
img

Dimitri Metzger

Digital, Data & IT Business Partner for Development & Medical Units & AI
Merck

11:50 - 12:20 Innovation and Digital Trials: A Practical Perspective from R&D

Roberta Pandolfi - Analytics Innovation Strategist, Boehringer Ingelheim
  • Reflections on the current state of digital trial innovation and why R&D still lags behind commercial and marketing domains
  • Internal experiments and learnings from Boehringer Ingelheim and previous roles — including in silico research and early exploration of agent-based systems
  • Outlook on what’s next: digital protocols, collaboration models with the SMI industry, and the potential of GenAI/agentic AI in clinical operations
img

Roberta Pandolfi

Analytics Innovation Strategist
Boehringer Ingelheim

12:20 - 13:50 Lunch Break

Table A - in front of Room Zoo 2

13:50 - 14:20 RWE, REGULATORY FRAMEWORK AND APPLICATION IN CLINICAL TRIALS
Ana Serrato - Head of Clinical Development, Avextra

-How can real-world evidence improve Phase 4 clinical trials?

-New regulatory framework enabling effective use of RWE

-Laying the groundwork for the use of AI and other technologies to increase efficiency and save time and costs

img

Ana Serrato

Head of Clinical Development
Avextra

Table B - in Room Zoo 2

13:50 - 14:20 APPLICATION OF SYNTHETIC DATA IN CLINICAL TRIALS AND PHARMACEUTICAL RESEARCH
Elmar Diederichs - Mathematician, HealthCare Futurists GmbH

-Learn about practical applications of synthetic data in clinical trial design, patient simulation, and rare disease research.

-Discuss key challenges, including regulatory acceptance, data quality validation, and ethical considerations.

-Share strategies for integrating synthetic datasets to improve model training, study diversity, and data protection.

img

Elmar Diederichs

Mathematician
HealthCare Futurists GmbH

  • AI in Pharma & Biotech 
  • Use cases & solutions 
  • Challenges & Lessons Learned 
img

Dr. Frank Richard

Vice President Medical, AI and Machine Learning, Oncology Drug Development
Heidelberg Pharma AG

14:50 - 15:20 Closing Keynote: Microsoft’s AI Applications in Pharma

Sonika Kapil - AI & App Chief Architect, Microsoft

-Enhancing Drug Discovery: Explore how Microsoft’s AI technology accelerates the identification and validation of new drug targets through advanced data analytics and machine learning models.

-Optimizing Clinical Trials: Discover Microsoft’s role in improving the efficiency of clinical trial designs, participant selection, and outcome predictions using AIdriven

insights.

-Quantum AI: new frontiers of quantum computing and first applications in drug discovery

img

Sonika Kapil

AI & App Chief Architect
Microsoft

15:20 - 16:00 Coffee Break and Networking

Masterclass B - Room Europa 6

16:00 - 17:30 Microsoft’s AI Applications in Pharma and Practical Use Cases
Sonika Kapil - AI & App Chief Architect, Microsoft

In this masterclass, we focus on the solutions and applications presented in the previous presentation, while going into practical examples and case studies.


- Enhancing Drug Discovery: Explore how Microsoft’s AI technology accelerates the identification and validation of new drug targets through advanced data analytics and machine learning models.

-Optimizing Clinical Trials: Discover Microsoft’s role in improving the efficiency of clinical trial designs, participant selection, and outcome predictions using AI-driven insights.

-Quantum AI: new frontiers of quantum computing and first applications in drug discovery

img

Sonika Kapil

AI & App Chief Architect
Microsoft

Masterclass C - Room Europa 2

16:00 - 17:30 AI Ready: Ihre Organisation fit für die KI-Zukunft
Dimitri Metzger - Digital, Data & IT Business Partner for Development & Medical Units & AI, Merck

Diese interaktive Masterclass richtet sich an Führungskräfte und Teams, die bereit sind, die Leistungsfähigkeit der KI in ihrem täglichen Betrieb zu nutzen. Unser Ziel ist es, KI zu entmystifizieren und Sie mit umsetzbaren Strategien auszustatten, um die Kompetenz Ihres Unternehmens bei der Nutzung dieser transformativen Technologie zu verbessern. Während des Workshops werden wir uns mit drei Schlüsselbereichen befassen:

-Was ist Everyday AI und wie kann man Unternehmen weiterbilden?

-Wie können Unternehmen in die Lage versetzt werden, Champions bei der täglichen Nutzung von KI zu werden und ihre Anwendungsfälle voranzutreiben?

-Wie kann man den Fortschritt messen und an die Geschäftsleitung berichten?

img

Dimitri Metzger

Digital, Data & IT Business Partner for Development & Medical Units & AI
Merck